OE-005 Additive Protection of Ischemic Heart by Combined Treatment with a Delta PKC Inhibitor and an Epsilon PKC Activator(Acute Myocardial Infarction, Basic 1 (IHD) : OE1)(Oral Presentation (English))
スポンサーリンク
概要
- 論文の詳細を見る
- 社団法人日本循環器学会の論文
- 2004-03-01
著者
-
Kaneda Hideaki
Department of Cardiology
-
Ikeno Fumiaki
Department Of Cardiovascular Medicine Stanford University School Of Medicine
-
Inagaki Koichi
Department Of Cardiology Otsu Red Cross Hospital
-
Inagaki Koichi
Department Of Molecular Pharmacology Stanford University School Of Medicine
-
Inagaki Koichi
Department Of Applied Physics Waseda University
-
Ikeno Fumiaki
Department Of Cardiovascular Medicine Stanford University
-
Kaneda Hideaki
Department Of Cardiovascular Medicine Stanford University School Of Medicine
-
Chen Leon
Department of Molecular Pharmacology, Stanford University School of Medicine
-
Lee Felix
Department of Cardiovascular Medicine, Stanford University School of Medicine
-
Rezaee Mehrdad
Department of Cardiovascular Medicine, Stanford University School of Medicine
-
Mochly-Rosen Daria
Department of Molecular Pharmacology, Stanford University School of Medicine
-
Lee Felix
Department Of Cardiovascular Medicine Stanford University School Of Medicine
-
Chen Leon
Department Of Molecular Pharmacology Stanford University School Of Medicine
-
Rezaee Mehrdad
Department Of Cardiovascular Medicine Stanford University School Of Medicine
-
Mochly-rosen Daria
Department Of Molecular Pharmacology Stanford University School Of Medicine
-
Mochly-rosen Daria
Department Of Chemical And Systems Biology Stanford University School Of Medicine
-
Ikeno Fumiaki
Department of Cardiology, Tokyo Women's Medical University
関連論文
- Intriguing Peri-Strut Low-Intensity Area Detected by Optical Coherence Tomography After Coronary Stent Deployment
- PE-181 The Outcome of Patients Who Stopped the Antiplatelet Therapy for the Operations after Stent Implantations(Thromboembolism/Antithrombotic therapy/Thrombolysis-3, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- PE-084 Late Angiographic Stent Thrombosis (LAST) after Cypher Stents Imaplantation(Coronary revascularization, PCI-8 (IHD) PE14,Poster Session (English),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society)
- IS071 Differential Pathophysiological Roles of Angiotensin II and Endothelin-1 in the Myocardium during Transition from Pressure-overload Hypertrophy to Heart Failure in Hypertensive Rats
- PJ-545 Increased Washout Rate of Technetium-99m Sestamibi in Cancer Patients after Anthracyclines Administration(Nuclear cardiology(09)(I),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- PJ-680 Comparison of 4D-MSPECT and QGS for Detection of Wall Motion Abnormality in Patients with Coronary Artery Disease(Nuclear cardiology-8, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- Coronary Artery Spasm and the Polymorphisms of the Endothelial Nitric Oxide Synthase Gene
- OE-005 Additive Protection of Ischemic Heart by Combined Treatment with a Delta PKC Inhibitor and an Epsilon PKC Activator(Acute Myocardial Infarction, Basic 1 (IHD) : OE1)(Oral Presentation (English))
- Large Dielectric Constant and Giant Nonlinear Conduction in the Organic Conductor θ-(BEDT-TTF)_2CsZn(SCN)_4(Condensed Matter : Electronic Structure, Electrical, Magnetic and Optical Properties)
- Identification of εPKC Targets During Cardiac Ischemic Injury
- Nitroglycerin Use in Myocardial Infarction Patients : Risks and Benefits
- Global Cardiovascular Device Innovation: Japan-USA Synergies:– Harmonization by Doing (HBD) Program, a Consortium of Regulatory Agencies, Medical Device Industry, and Academic Institutions –
- Large Dielectric Constant and Giant Nonlinear Conduction in the Organic Conductor θ-(BEDT-TTF)_2CsZn(SCN)_4(Condensed Matter : Electronic Structure, Electrical, Magnetic and Optical Properties)
- Global Cardiovascular Device Innovation : Japan-USA Synergies : Harmonization by Doing (HBD) Program, a Consortium of Regulatory Agencies, Medical Device Industry, and Academic Institutions